BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 249 filers reported holding BLUEBIRD BIO INC in Q3 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $8,922,000 | -38.9% | 50,100 | -52.9% | 0.13% | -21.6% |
Q3 2017 | $14,600,000 | +32.6% | 106,300 | +1.4% | 0.17% | +0.6% |
Q2 2017 | $11,009,000 | +1395.8% | 104,800 | +1193.8% | 0.17% | +1409.1% |
Q1 2017 | $736,000 | -76.7% | 8,100 | -82.7% | 0.01% | -89.4% |
Q3 2016 | $3,165,000 | -29.6% | 46,700 | +74.9% | 0.10% | -84.6% |
Q2 2015 | $4,495,000 | +300.3% | 26,700 | +187.1% | 0.68% | +526.9% |
Q1 2015 | $1,123,000 | – | 9,300 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |